Table 1. Characteristics of Tamoxifen and Docetaxel/Paclitaxel Users.

Characteristic	Tamoxifen	Docetaxel/paclitaxel
Epiphora
No.	16 395	1824
Age, y, mean (SD)	54.6 (12.8)	62.1 (12.7)
Follow-up, y, mean (SD)	3.5 (3.1)	2.0 (1.9)
Events, No.	45	20
Rate	7.9/10 000 person years	55.6/10 000 person years
Keratoconjunctivitis, %	0.05	0.11
Dry eye syndrome, %	0.29	2.25
Keratitis, %	2.07	3.95
Blepharitis, %	2.16	4.61
Eyelid malposition, %	0.55	1.35
Cystoid macular edema
No.	16 524	1909
Age, y, mean (SD)	54.6 (12.8)	62.5 (12.8)
Follow-up, y, mean (SD)	3.5 (3.1)	2.0 (1.9)
Events, No.	96	13
Rate	16.8/10 000 person years	34.8/10 000 person years
Cataract, %	0.6	2.1
Diabetes, %	8.0	14.3
Optic neuropathy
No.	16 395	1824
Age, y, mean (SD)	54.6 (12.8)	62.5 (12.8)
Follow-up, y, mean (SD)	3.5 (3.1)	2.0 (1.9)
Events, No.	7	4
Rate	1.2/10 000 person years	10.6/10 000 person years
Hypertension, %	6.0	38.2
Diabetes, %	9.9	17.4
Coronary artery disease, %	5.7	18.6